Careers in Quality

We are: The Molecular Diagnostics Service in the Department of Pathology develops and performs numerous sophisticated clinical laboratory tests for the comprehensive molecular profiling of tumors. This helps clinicians define cancer diagnoses and make treatment decisions, including enrollment in clinical trials. The Next Generation Sequencing (NGS) laboratory, within the Molecular Diagnostics Service, is a cutting-edge clinical laboratory with access to the most advanced molecular technologies and high-throughput sequencing instruments. Two of the premier tests we have developed are MSK-IMPACT and MSK-ACCESS. MSK-IMPACT has been authorized by the US Food & Drug Administration as a clinical test and has been used to profile tum